150 GDH1 is highly expressed in most tumor samples and correlated with tumor progression stage, including breast cancer and lung cancer cells
One friend got super-shredded within 2 months despite eating less than stellar non-stop
Shortage of diabetes, weight-loss drug Ozempic expected in Canada, says manufacturer Novo Nordisk says it is experiencing a temporary supply disruption with an injection pen A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk and Health Canada said on Friday
Key preclinical findings included: Dose-dependent weight loss exceeding that of single- or dual-receptor agonists Improved glucose tolerance and insulin sensitivity Increased energy expenditure attributable to the glucagon receptor component Reduced hepatic steatosis Acceptable preclinical safety and toxicology profile These data supported an Investigational New Drug (IND) application to the FDA, enabling the transition to human clinical testing
Thinking about using peptides like BPC-157, CJC-1295, or Ipamorelin around shoulder surgery
As more clinical data demonstrates that GLP-1 medications produce sustained weight loss and reduce obesity-related comorbidities, coverage is expanding
